- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04460391
Influence of Early Standing Training on ICU Patients
July 1, 2020 updated by: wang kaifei, Chinese PLA General Hospital
Influence of early standing training on ICU patients
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Objective: To study the effect of early standing training on ICU patients.Background: Early severe rehabilitation is of great significance for patients, which can help patients withdraw from mechanical ventilation as soon as possible, improve pulmonary ventilation, and promote early walking.However, patients on mechanical ventilation are more prone to delirium, muscle weakness, ventilator dependence and other problems.
Early standing training can significantly improve patients' lower limb muscle strength, improve diaphragm function, improve the prognosis of patients, and reduce the length of hospital stay.Methods: selecting stable hemodynamics in ICU patients with mechanical ventilation, randomly divided into two groups, a group of routine rehabilitation training, another group stand for regular rehabilitation and early training, with the aid of electric beds, on the first day of patients, to evaluate the seventh day, the 14th day, and collect the basic information for patients and strength assessment, blood gas analysis, the diaphragm of the bed and ultrasound and muscle ultrasound, and record the patient's mortality within 28 days, the incidence of delirium, decannulation rate, etc., recorded in patients with mechanical ventilation time and the time required to walk independently and ICU stay time.
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Zhao Ying
- Phone Number: 17600953801 17600953801
- Email: 1412888703@qq.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The age is ≥ 18 years old;
- the hemodynamics is stable;
- 50 < heart rate < 120 beats / min ;
- 90 < systolic blood pressure < 200mmHg ;
- 55 < mean arterial pressure < 120mmHg;
- do not increase the dose of pressor drugs for at least 2 hours;
- intracranial pressure is stable and there are no seizures within 24 hours;
- the respiratory state is stable;
- the patient's finger pulse oxygen saturation ≥ 88%;
- Oxygen concentration less than 60%;
- Terminal positive expiratory pressure<12cmH2O;
- 10 < respiratory frequency < 35 beats / min.
Exclusion Criteria:
- Pregnancy;
- acute cardio-cerebrovascular events;
- spinal or limb fractures;
- active bleeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: experimental group
Early standing training and routine rehabilitation
|
Early standing training and routine rehabilitation
|
Active Comparator: control group
Conventional rehabilitation,Muscle training and breathing training
|
Early standing training and routine rehabilitation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medical Research Council
Time Frame: day 1
|
Muscle strength assessment of ICU patients,Out of 60 points,Less than 48 points had acquired muscle weakness in the ICU.
|
day 1
|
Medical Research Council
Time Frame: day 7
|
Muscle strength assessment of ICU patients,Out of 60 points,Less than 48 points had acquired muscle weakness in the ICU.
|
day 7
|
Medical Research Council
Time Frame: day 14
|
Muscle strength assessment of ICU patients,Out of 60 points,Less than 48 points had acquired muscle weakness in the ICU.
|
day 14
|
Berg Balance Scale
Time Frame: day 1
|
Balance grade score,The highest 56 points,The higher the score, the better the balance.
|
day 1
|
Berg Balance Scale
Time Frame: day 7
|
Balance grade score,The highest 56 points,The higher the score, the better the balance.
|
day 7
|
Berg Balance Scale
Time Frame: day 14
|
Balance grade score,The highest 56 points,The higher the score, the better the balance.
|
day 14
|
FIM Function Independent Scale
Time Frame: day 1
|
Functional independence assessment,The lowest score is 18 and the highest is 126,The higher the score, the more independent it is.
|
day 1
|
FIM Function Independent Scale
Time Frame: day 7
|
Functional independence assessment,The lowest score is 18 and the highest is 126,The higher the score, the more independent it is.
|
day 7
|
FIM Function Independent Scale
Time Frame: day 14
|
Functional independence assessment,The lowest score is 18 and the highest is 126,The higher the score, the more independent it is.
|
day 14
|
Holden walk classification
Time Frame: day 1
|
Levels 0 to 5,The higher the grade, the better the ability to walk
|
day 1
|
Holden walk classification
Time Frame: day 7
|
Levels 0 to 5,The higher the grade, the better the ability to walk
|
day 7
|
Holden walk classification
Time Frame: day 14
|
Levels 0 to 5,The higher the grade, the better the ability to walk
|
day 14
|
arterial blood gas analysis
Time Frame: day 1
|
PH,normal range 7.35-7.45
|
day 1
|
arterial blood gas analysis
Time Frame: day 7
|
PH,normal range 7.35-7.45
|
day 7
|
arterial blood gas analysis
Time Frame: day 14
|
PH,normal range 7.35-7.45
|
day 14
|
partial pressure of carbon dioxide
Time Frame: day 1
|
normal range 35-45 mmHg
|
day 1
|
partial pressure of carbon dioxide
Time Frame: day 7
|
normal range 35-45 mmHg
|
day 7
|
partial pressure of carbon dioxide
Time Frame: day 14
|
normal range 35-45 mmHg
|
day 14
|
oxygenation index
Time Frame: day 1
|
Normal adults are 400,the higher,the better
|
day 1
|
oxygenation index
Time Frame: day 7
|
Normal adults are 400,the higher,the better
|
day 7
|
oxygenation index
Time Frame: day 14
|
Normal adults are 400,the higher,the better
|
day 14
|
lactic acid
Time Frame: day 1
|
normal range 0.5-1.6mmol/L
|
day 1
|
lactic acid
Time Frame: day 7
|
normal range 0.5-1.6mmol/L
|
day 7
|
lactic acid
Time Frame: day 14
|
normal range 0.5-1.6mmol/L
|
day 14
|
Diaphragmatic movement
Time Frame: day 1
|
The distance the diaphragm moves downward during inhalation,Normal adults are 1.4cm.
|
day 1
|
Diaphragmatic movement
Time Frame: day 7
|
The distance the diaphragm moves downward during inhalation,Normal adults are 1.4cm.
|
day 7
|
Diaphragmatic movement
Time Frame: day 14
|
The distance the diaphragm moves downward during inhalation,Normal adults are 1.4cm.
|
day 14
|
Diaphragm contraction rate
Time Frame: day 1
|
Normal adults are 1.3cm/s
|
day 1
|
Diaphragm contraction rate
Time Frame: day 7
|
Normal adults are 1.3cm/s
|
day 7
|
Diaphragm contraction rate
Time Frame: day 14
|
Normal adults are 1.3cm/s
|
day 14
|
Diaphragm thickness at end of breath
Time Frame: day 1
|
Normal adults are 0.15cm
|
day 1
|
Diaphragm thickness at end of breath
Time Frame: day 7
|
Normal adults are 0.15cm
|
day 7
|
Diaphragm thickness at end of breath
Time Frame: day 14
|
Normal adults are 0.15cm
|
day 14
|
Diaphragm thickness at end of inhalation
Time Frame: day 1
|
Normal adults are 0.28cm
|
day 1
|
Diaphragm thickness at end of inhalation
Time Frame: day 7
|
Normal adults are 0.28cm
|
day 7
|
Diaphragm thickness at end of inhalation
Time Frame: day 14
|
Normal adults are 0.28cm
|
day 14
|
Diaphragmatic thickness variation rate
Time Frame: day 1
|
Less than 20% have diaphragmatic dysfunction
|
day 1
|
Diaphragmatic thickness variation rate
Time Frame: day 7
|
Less than 20% have diaphragmatic dysfunction
|
day 7
|
Diaphragmatic thickness variation rate
Time Frame: day 14
|
Less than 20% have diaphragmatic dysfunction
|
day 14
|
E-T index
Time Frame: day 1
|
Product of inspiratory time and diaphragmatic mobility,The higher the extubation success rate, the higher the extubation success rate.
|
day 1
|
E-T index
Time Frame: day 7
|
Product of inspiratory time and diaphragmatic mobility,The higher the extubation success rate, the higher the extubation success rate.
|
day 7
|
E-T index
Time Frame: day 14
|
Product of inspiratory time and diaphragmatic mobility,The higher the extubation success rate, the higher the extubation success rate.
|
day 14
|
Timed Inspiration
Time Frame: day 1
|
Normal adults are 1s
|
day 1
|
Timed Inspiration
Time Frame: day 7
|
Normal adults are 1s
|
day 7
|
Timed Inspiration
Time Frame: day 14
|
Normal adults are 1s
|
day 14
|
Rectus femoris thickness
Time Frame: day 1
|
The thicker the muscle, the better
|
day 1
|
Rectus femoris thickness
Time Frame: day 7
|
The thicker the muscle, the better
|
day 7
|
Rectus femoris thickness
Time Frame: day 14
|
The thicker the muscle, the better
|
day 14
|
Thickness of tibialis anterior muscle
Time Frame: day 1
|
The thicker the muscle, the better
|
day 1
|
Thickness of tibialis anterior muscle
Time Frame: day 7
|
The thicker the muscle, the better
|
day 7
|
Thickness of tibialis anterior muscle
Time Frame: day 14
|
The thicker the muscle, the better
|
day 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mechanical ventilation time
Time Frame: three months
|
Mechanical ventilation time
|
three months
|
icu length of stay
Time Frame: three months
|
icu length of stay
|
three months
|
Time required for independent walking
Time Frame: three months
|
Time required for independent walking
|
three months
|
delirium
Time Frame: 28 days
|
Confusion Assessment Method of the Intensive Care Unit.
Positive is delirium.
|
28 days
|
mortality
Time Frame: 28 days
|
mortality
|
28 days
|
reintubation
Time Frame: 28 days
|
Note whether intubation was performed within 28 days.
|
28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: xin li xie, The First Medical Center of PLA General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
October 1, 2020
Primary Completion (Anticipated)
October 1, 2021
Study Completion (Anticipated)
October 1, 2021
Study Registration Dates
First Submitted
June 26, 2020
First Submitted That Met QC Criteria
July 1, 2020
First Posted (Actual)
July 7, 2020
Study Record Updates
Last Update Posted (Actual)
July 7, 2020
Last Update Submitted That Met QC Criteria
July 1, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Intensive rehabilitation
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Disease
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Astellas Pharma Global Development, Inc.CytokineticsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaParexel International Ltd; Cognizant Technology Solution; Center for Information... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Canada, France, Russian Federation, Ukraine, Hungary, Bulgaria
-
University of ZurichNational Center of Cardiology and Internal Medicine named after academician...CompletedChronic Obstructive Pulmonary Disease (COPD)Kyrgyzstan
Clinical Trials on Intensive rehabilitation
-
Centre for Interdisciplinary Research in Rehabilitation...Recruiting
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Samsung Medical CenterCompletedStroke | Rehabilitation | Motor FunctionKorea, Republic of
-
University of California, San DiegoThe Cleveland Clinic; Salk Institute for Biological StudiesRecruitingCoronary Artery DiseaseUnited States
-
KU LeuvenVrije Universiteit Brussel; AZ HerentalsRecruitingStroke | Chronic Disease | Spinal Cord InjuriesBelgium
-
Hasselt UniversityJessa HospitalCompletedChronic Non-specific Low Back PainBelgium
-
Cairo UniversityNot yet recruitingPost-COVID-19 Syndrome
-
Fondation Ellen PoidatzRecruiting
-
Clinique Les Trois SoleilsCHU de Reims; Clinalliance Villiers-sur-Orge; Centre de Rééducation Fonctionnelle... and other collaboratorsRecruiting
-
Ospedale Generale Di Zona Moriggia-PelasciniCompletedParkinson Disease | Rehabilitation | Dexterity